A Study of SGN-MesoC2 in Advanced Solid Tumors

Clinical trial NCT06466187 · TERMINATED

Trial details

NCT number: NCT06466187
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Pancreatic Adenocarcinoma Colorectal Neoplasms Mesothelioma Other Solid Tumors Endometrial

Start date: 2024-08-02
Primary completion: 2026-05-27
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.